Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production - Promising therapeutic strategy

Central European Journal of Biology

Volumn 1, Issue 4, 2006, Pages 584-593

  Hofer, Michal ^a   Pospíšil, Milan ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Cyclooxygenase 2; Haematopoiesis; Non steroidal anti inflammatory drugs

Indexed keywords

EID: 33845946789     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-006-0033-3     Document Type: Article

References (66)

1. L.I. Zion (Ed.): Hematopoiesis: A Developmental Approach, Oxford University Press, New York, 2001.
2. R.H. Brady and C.N. Serhan: "The prostaglandins, leukotrienes, lipoxins, and platelet-activating factor", In: L.H. Sigal and Y. Ron (Eds.): Immunology and Inflammation, Basic Mechanisms and Clinical Consequences, McGraw Hill, Inc., New York, 1993, pp. 271-286.
3. W.L. Smith, D.L. DeWitt and R.M. Garavito: "Cyclooxygenases: Structural, cellular, and molecular biology", Ann. Rev. Biochem., Vol. 68, (2000), pp. 145-182.
4. R.M. Garavito and A.M. Mulichak: "The structure of mammalian cyclooxygenases", Ann. Rev. Biophys. Biomol. Struct., Vol. 32, (2003), pp. 183-206.
5. R.W. Dubois, G.Y. Melmed, J.M. Henning and L. Laine: "Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclooxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy", Alim. Pharmac. Therap., Vol. 19, (2004), pp. 197-208.
6. M. Maravic, C. Berge, J.P. Daures and M.C. Boissier: "Practices for managing a flare of long-standing rheumatoid arthritis: Survey among French rheumatologists", Clin. Exp. Rheumatol, Vol. 23, (2005), pp. 36-42.
7. R.E. Harris, J. Beebe-Donk, H. Doss and D.B. Doss: "Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade", Oncol. Rep., Vol. 13, (2005), pp. 559-583.
8. D. Pereg and M. Lishner: "Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer", J. Int. Med., Vol. 258, (2005), pp. 115-123.
9. T.C. Pellmar, S. Rockwell and the Radiological/Nuclear Threat Countermeasures Working Group: "Priority list of research areas for radiological nuclear threat countermeasures, Radiat. Res., Vol. 163, (2005), pp. 115-123.
10. 2", Blood, Vol. 62, (1983), pp. 1100-1107.
11. G.A. Boorman, M.I. Luster, J.H. Dean and R.W. Luebke: "Effect of indomethacin on the bone marow and immune system of the mouse", J. Lab. Clin. Immunol., Vol. 7, (1982), pp. 119-126.
12. J. Kurland and M.A.S. Moore: "Modulation of hemopoiesis by prostaglandins", Exp. Hematol., Vol. 5, (1977), pp. 357-373.
13. J. Fontagné, M. Adolphe, M. Semichon, L. Zizine and P. Lechat: "Effect of in vivo treatment with indomethacin on mouse granulocyte-macrophage colony-forming cells in culture (CFUc). Possible role of prostaglandins", Exp. Hematol., Vol. 8, (1980), pp. 1157-1164.
14. 2: demonstration of a novel mechanism of action in vivo", Immunol. Res., Vol. 8, (1989), pp. 176-184.
15. Y. Niho, H. Niiro, Y. Tanaka, H. Nakashima and T. Otsuka: "Role of IL-10 in the crossregulation of prostaglandins and cytokines in monocytes", Acta Haematol, Vol. 99, (1998), pp. 165-170.
16. H.K. Takahshi, H. Iwagaki, R. Tamura, D. Xue, M. Sano, S. Mori, T. Yoshino, N. Tanaka and M. Nishibori: "Unique regulation profile of prostaglandin E-1 on adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells", J. Pharmacol. Exp. Therap., Vol. 307, (2003), pp. 1188-1195.
17. D.M. Chang, P. Baptiste and P.H. Chur: "The effect of antirheumatic drugs on interleukin-1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes", J. Rheumatol, Vol. 17, (1990), pp. 1148-1157.
18. G. Lozanski, S.P. Ballou and I. Kushner: "Effect of flurbiprofen on cytokine production by human monocytes and U-937 and THP-1 cell-lines", J. Rheumatol., Vol. 19, (1992), pp. 921-926.
19. Z. Estrov and P. Resnitzky: "Enhancement of hemopoietic stem cell proliferation by prostaglandin inhibitor drugs", Exp. Hematol., Vol. 11, (1983), pp. 802-809.
20. G.A. Boorman, M.I. Luster, J.H. Dean and R.W. Luebke: "Effect of indomethacin on the bone marrow and immune system of the mouse", J. Clin. Lab. Immunol., Vol. 7, (1982), pp. 119-126.
21. K. Taniguchi, Y. Koga, M. Kato and K. Nomoto: "The in vivo regulation of splenic T cell population by the prostagiandin-mediated system", J. Clin. Lab. Immunol., Vol. 14, (1984), pp. 195-203.
22. V. Kalaidjieva: "Modulation of erythropoiesis in rat bone marrow erythroblastic islands by cyclooxygenase inhibition", Gen. Pharmacol., Vol. 32, (1999), pp. 423-428.
23. Y. Furuta, N. Hunter, T. Barkley, E. Hall and L. Milas: "Increase in radioresponse of murine tumors by treatment with indomethacin", Cancer Res., Vol. 48, (1988), pp. 3008-3013.
24. A. Kozubík, M. Pospíšil and J. Netí ková: "The stimulatory effect of single-dose pre-irradiation administration of indomethacin and diclofenac on hematopoietic recovery in the spleen of gamma-irradiated mice", Studia Biophys., Vol. 131, (1989), pp. 93 101.
25. I. Nishiguchi, Y. Furuta, N. Hunter, D. Murray and L. Milas: "Radioprotection of haematopoietic tissues by indomethacin", Radiat. Res., Vol. 122, (1990), pp. 188-192.
26. I.E. Sklobovskaya, L.P. Zhavoronkov and R.V. Dubovik: "Haemostimulating efficiency of prostaglandin biosynthesis inhibitors in conditions of fractionated irradiation", Radiobiologiya, Vol. 26, (1986), pp. 185-188 (in Russian).
27. M. Hofer, M. Pospíšil and I. Pipalová: "Radioprotective effects of flurbiprofen", Folia Biol (Praha), Vol. 42, (1996), pp. 267-269.
28. M. Hofer, M. Pospíšil, I. Pipalová and J. Holá: "Modulation of haemopoietic radiation response of mice by diclofenac in fractionated treatment", Physiol. Res., Vol. 45, (1996), pp. 213-220.
29. M. Pospíšil, J. Netíková and A. Kozubík: "Enhancement of haemopoietic recovery by indomethacin after sub lethal whole-body gamma irradiation", Acta Radiol. Oncol., Vol. 25, (1986), pp. 195-198.
30. M. Pospíšil, J. Netíková, A. Kozubík and I. Pipalová: "Effect of indomethacin, diclofenac sodium and sodium salicylate on peripheral blood cell counts in sublethally gamma-irradiated mice", Strahlenther. Oncol., Vol. 165, (1989), pp. 627-631.
31. B.A. Serushago, K. Tanaka, Y. Koga, K. Taniguchi and K. Nomoto: "Positive effects of indomethacin on restoration of splenic nucleated cell population in mice given sublethal irradiation", Immunopharmacology, Vol. 14, (1987), pp. 21-26.
32. A. Kozubík, M. Pospíšil, Š. Viklická, L. Tkadleček and J. Netíková: "Effect of indomethacin on the proliferation and differentiation activity in the haemopoietic system of lethally irradiated mice after syngeneic bone marrow transplantation", Folia Biol. (Praha), Vol. 33, (1987), pp. 418-423.
33. E. Mišúrová, K. Kropáčová, O. Chlebovský and D. Pado: "The effect of indomethacin on nucleic acids in blood, hemopoietic and lymphoid tissues in continuously irradiated rats", Neoplasma, Vol. 36, (1989), pp. 541-547.
34. M. Hofer, Z. Hoferová, P. Fedoročko and N.O. Macková: "Hematopoiesis-stimulating and anti-tumor effects of repeated administration of diclofenac in mice with transplanted fibrosarcoma cells", Physiol. Res., Vol. 51, (2002), pp. 629-632.
35. M. Pospíšil, M. Hofer, I. Pipalová, Š. Viklická, J. Netíková and J. Šandula: "Enhancement of hematopoietic recovery in gamma-irradiated mice by the joint use of diclofenac, an inhibitor of prostaglandin production, and glucan, a macrophage activator", Exp. Hematol., Vol. 20, (1992), pp. 891-895.
36. M. Hofer, M. Pospíšil, Š. Viklická, A. Vacek, I. Pipalová and A. Bartoníčková: "Hematopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan", J. Leukoc. Biol., Vol. 53, (1993), pp. 185-189.
37. P. Fedoročko and N.O. Macková: "Combined modality radioprotection: Enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and indomethacin", Int. J. Immunopharmac., Vol. 18, (1996), pp. 329-337.
38. N.O. Macková and P. Fedoročko: "Effect of liposomal muramyl tripeptide phosphatidylethanolamine and indomethacin on hematopoietic recovery in irradiated mice", Physiol. Res., Vol. 51, (2002), pp. 511-521.
39. P. Fedoročko and N.O. Macková: "Radioprotective effects of combination of bronchovaxom, a macrophage activator, and indomethacin, an inhibitor of prostaglandin production: Relationship to myelopoiesis", Eur. J. Haematol, Vol. 56, (1996), pp. 54-61.
40. I.E. Sklobovskaya and L.P. Zhavoronkov: "The combined effect of chemical radiopro tective agents and prostaglandin biosynthesis inhibitors on postirradiation recovery of mouse haemopoiesis", Radiobiologiya, Vol. 26, (1986), pp. 61-64 (in Russian).
41. A. Kozubík, M. Pospíšil and J. Netí ková: "Enhancement of haemopoietic recovery in sublethally gama-irradiated mice by the joint use of indomethacin and cystamine", Folia Biol. (Praha), Vol. 36, (1990), pp. 291-300.
42. A. Kozubík, M. Pospíšil and J. Netí ková: "Possibilities of the combined use of nonsteroidal anti-inflammatory drugs and sulfhydryl compounds in radioprotection", Strahlenther. Onkol., Vol. 167, (1991), pp. 186-190.
43. J. Fontagné, R. Bertin, F. Demarco, L. Zizine, M. Adolphe, R. Portet and P. Lechat: "Invivo effects of indomethacin and cyclophosphamide on CFU-GM proliferation and cyclic-nucleotide levels in bone marrow of mice", Biomed. Pharmacol., Vol. 37, (1983), pp. 452-457.
44. D.A. Nickevich, M.R. Young, N.K. Ellis and H.T. Wepsich: "Stimulation of hematopoiesis in untreated and cyclophosphamide-treated mice by the inhibition of prostaglandin synthesis", J. Immunopharmac., Vol. 8, (1986), pp. 299-313.
45. M. O'Reilly and R.L. Gamelli: "Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment", Exp. Hematol., Vol. 18, (1990), pp. 974-978.
46. A.S. Michalowski: "On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs", Acta Oncol., Vol. 33, (1994), pp. 139-157.
47. U.S. Akarca: "Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs", Curr. Pharm. Des., Vol. 11, (2005), pp. 1779-1793.
48. J.Y. Wang, S. Yamasaki, K. Takeuchi and S. Okabe: "Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin", Gastroenterology, Vol. 96, (1989), pp. 393-402.
49. T. Mahmud, D.L. Scott and I. Bjarnason: "A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity", Ann. Rheum. Dis., Vol. 55, (1996), pp. 211-213.
50. G.L. Floersheim: "Allopurinol, indomethacin and riboflavin enhance radiation lethality in mice", Radiat. Res., Vol. 139, (1994), pp. 240-247.
51. M. Hofer, M. Pospíšil, L. Tkadleček, Š. Viklická and I. Pipalová: "Low survival of mice following lethal gamma-irradiation after administration of inhibitors of prostaglandin synthesis", Physiol. Res., Vol. 41, (1992), pp. 157-161.
52. J.L. Wallace, B. Reuter, C. Cicala, W. McKnight, M.B. Grisham and G. Cirino: "Novel nonsteroidal antiinflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat", Gastroenterology, Vol. 107, (1994), pp. 173-179.
53. L. Juchelková, M. Hofer, M. Pospíšil and I. Pipalová: "Radioprotective effects of flurbiprofen and its nitroderivative", Physiol. Res., Vol. 47, (1998), pp. 73-80.
54. J.C. Frölich: "A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes", Trends Pharmacol. Sci., Vol. 18, (1997), pp. 30-34.
55. L.J. Crofford, P.E. Lipsky, P. Brooks, S.B. Abramson, L.S. Simon and L.B.A. Van de Putte: "Basic biology and clinical application of specific cyclooxygenase-2 inhibitors", Arthr. Rheum., Vol. 43, (2000), pp. 4-13.
56. H. Mizuno, C. Sakamoto, K. Matsuda, K. Wada, T. Uchida, H. Noguchi, T. Akamatsu and M. Kasuga: "Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice", Gastroenterology, Vol. 112, (1997), pp. 387-397.
57. J.I. Shigeta, S. Takahashi and S. Okabe: "Role of cycloogygenase-2 in the healing of gastric ulcers in rats", J. Pharmacol. Exp. Therap., Vol. 286, (1998), pp. 1383-1390.
58. A. Lanas, J. Panés and J.M. Piqué: "Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract", Curr. Pharm. Des., Vol. 9, (2003), pp. 2253-2266.
59. M. Shoup, L.K. He, H. Liu, R. Shankar and R. Gamelli: "Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection", J. Trauma/Inj. Inf. Crit. Care, Vol. 45, (1998), pp. 215-220.
60. M. Lorenz, H.S. Slaughter, D.M. Wescott, S.I. Carter, B. Schnyder, J.E. Dinchuk and B.D. Car: "Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice", Exp. Hematol., Vol. 27, (1999), 1494-1502.
61. 2 generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach", Pharmacology, Vol. 61, (2000), pp. 244-250.
62. M. Hofer, M. Pospíšil, V. Znojil, J. Holá, A. Vacek, L. Weiterová, D. Štreitová and A. Kozubík: "Meloxicam, a cyclooxygenase-2 inhibitor, supports hematopoietic recovery in gamma-irradiated mice", Radiat. Res., Vol. 166, (2006), pp. 556-560.
63. A.P. Goldman, C.S. Williams, H.M. Sheng, L.W. Lamps, V.P. Williams, M. Pairet, J.D. Morrow and R.N. DuBois: "Meloxicam inhibits the growth of colorectal cancer cells", Carcinogenesis, Vol. 19, (1998), pp. 2195-2199.
64. H.J. Hussey and M.J. Tisdale: "Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model", Int. J. Cancer, Vol. 87, (2000), pp. 95-100.
65. M.A. Kern, M.M. Schöneweiß, D. Sahi, M. Bahlo, A.M. Haugg, H.U. Kasper, H.P. Dienes, H. Käferstein, K. Breuhahn and P. Schirmbacher: "Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice", Carcinogenesis, Vol. 25, (2004), pp. 1193-1199.
66. F. Lefrere, J. Makke, J.P. Fermand, J.P. Marolleau, L. Dal Cortivo, C. Alberti, V. Mouton, M. Benbunan and J.M. Miclea: "Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma", Bone Marrow Transplant., Vol. 24, (1999), pp. 463-466.